Ocriplasmin: Is VMA Only the Beginning?
By: Tarek S. Hassan, MD
The first FDA-approved agent for
“chemical vitrectomy” is here.
How a Meningitis Outbreak Changed Compounding Pharmacies
By: Steve Lenier, Contributing Editor
Compounders, accrediting agencies,
regulators, and doctors have revisited their practices.
The EMR Transition: Year 1
By: Michael Engelbert, MD, PhD
It’s a net “good thing,” though significant improvements remain necessary.
Going Deeper and Wider
By: Zofia Michalewska, MD, PhD; Janusz Michalewski, MD; Jerzy Nawrocki, MD. PhD
New OCT technologies offer the possibility of imaging the choroid, retina, and vitreous.
Optic Pit Maculopathy: Where Is the Fluid?
By: Ryan Young, MD; Jonathan H. Tzu, MD; Harry W. Flynn, JR., MD
Upfront
By: Peter K. Kaiser, M.D.
Betting on alpha?
Guest Editorial
By: Didier H. Ducournau, MD
Strategies in retinal detachment surgery: The EVRS RD Study
News
Caution on use of anti-VEGF; Genes don’t predict response; device for image capture, transfer; and more
Book Review
By: Oriel Spierer, MD; Anat Loewenstein, MD
Comprehensive AMD reference out in second edition
Controversies In Care
By: Michael Colucciello, MD
Posterior-segment IOFB Treatment:
Timing and Approach
Surgical Precision
By: Steve Charles, MD, FACS, FICS
Aspiration Fluidics and Vitreous Cutting
Focus On
By: Jeffrey S. Eisenberg
TxCell Scanning Laser Delivery System